Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: Cross-sectional study

BMJ Open

Volumn 3, Issue 4, 2013, Pages

  Smith, Daniel J ^a   Langan, Julie ^a   McLean, Gary ^a   Guthrie, Bruce ^b   Mercer, Stewart W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONSTIPATION; CROSS-SECTIONAL STUDY; FEMALE; HEALTH; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PERIPHERAL VASCULAR DISEASE; PHYSICAL DISEASE; PRIMARY MEDICAL CARE; PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; UNITED KINGDOM; VIRUS HEPATITIS;

EID: 84877692315     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002808     Document Type: Article

References (36)

1. Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ 2011;343:d5422.
2. Wahlbeck K, Westman J, Nordentoft M, et al. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry 2011;199:453-8.
3. Laursen TM, Munk-Olsen T, Gasses C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS ONE 2011;6: e24597.
4. Crump C, Winkleby MA, Sundquist K, et al. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013;170:324-33.
5. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009;374:620-27.
6. Saha S, Chant D, McGrath J. A systematic review of mortality in schizohophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:609-16.
7. Laursen TM, Munk-Olsen T, Nordentoft M, et al. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder and schizophrenia. J Clin Psychiatry 2007;68:899-907. (Pubitemid 47015490)
8. Heila H, Haukka J, Suvisaari J, et al. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 2005;35:725-32. (Pubitemid 40716436)
9. Myles N, Newall HD, Curtis J. Tobacco use before, at and after first-episode psychosis: a systematic meta-analysis. J Clin Psychiatry 2012;73:468-75.
10. Akhtar S, Kelly C, Gallagher A, et al. Review: newer antipsychotic agents, carbohydrate metabolism and cardiovascular risk. Br J Diabetes Vasc Dis 2004;4:303-9. (Pubitemid 39462107)
11. Ole A Andreassen, Djurovic S, Wesley K Thompson, et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 2013;92:197-209.
12. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012;380:37-43.
13. Carstairs V, Morris R. Deprivation and health in Scotland: Aberdeen: Aberdeen University Press, 1991.
14. Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia. A population-based controlled study. J Gen Intern Med 2006;21:1133-7. (Pubitemid 44506864)
15. De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011;10:52-77.
16. Mitchell AJ, Lord O, Malone D. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis. Br J Psychiatry 2012;201:435-43.
17. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011;10:138-51.
18. Mackell JA, Harrison DJ, McDonnell DD. Relationship between preventative physical health care and mental health in individuals with schizophrenia: a survey of caregivers. Ment Health Serv Res 2005;7:225-8. (Pubitemid 43013251)
19. Mitchell AJ, Delaffon V, Vancampfort D, et al. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med2012;42:125-47.
20. Dickerson FB, McNary SW, Brown CH, et al. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care 2003;41:560-70.
21. Thornicroft G, Brohan E, Rose D, et al. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet2009;373:408-15.
22. Druss BG, Bradford WD, Rosenheck RA, et al. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 2001;58:565-72. (Pubitemid 32523736)
23. Mitchell AJ, Vancampfort D, Sweers K, et al. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr Bull 2013;39:306-18.
24. Nielsen J, Meyer JM. Risk factors for ileus in patients with schizophrenia. Schizophr Bull 2012;38:592-8.
25. De Hert M, Hudyana H, Dockx L, et al. Second-generation antipsychotics and constipation: a review of the literature. Eur Psychiatry 2011;26:34-44.
26. Kirkbride JB, Jones PB, Ullrich S, et al. Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London. Schizophr Bull2012 Epub ahead of print, doi: 10.1093/schbul/sbs151
27. Kapur N, Hunt I, Lunt M, et al. Primary care consultation predictors in men and women: a cohort study. Br J Gen Pract 2005;55:108-13. (Pubitemid 40246923)
28. Saha S, Chant D, McGrath J. Meta-analyses of the incidence and prevalence of schizophrenia: conceptual and methodological issues. Int J Methods Psychiatr Res 2008;17:55-61.
29. Leucht S, Burkard T, Henderson J, et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatrica Scandinavica 2007;116:317-33. (Pubitemid 47537428)
30. Truyers C, Buntinx F, De Lepeleire J, et al. Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice data. BMC Fam Pract 2011;12:132.
31. Langan J, Mercer SW, Smith DJ. Multimorbidity and mental health: can psychiatry rise to the challenge? Br J Psychiatry2013 (in press).
32. The King's Fund. Long-term conditions and mental health. Cost Comorbidities, 2012. http://www.kingsfund.org.uk/sites/files/kf/field/field- publication-file/long-term-conditions-mental-health-cost-comorbidities-naylor- feb12.pdf
33. Department of Health. No health without mental health: a cross-government mental health outcomes strategy for people of all ages, 2011.
34. London School of Economics. How mental illness loses out on the NHS, 2012.
35. Schizophrenia Commission. The Adandoned Illness (Schizophrenia Commission Report). 2012.
36. Osborn D PJ, King MB, Nazareth I. Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice. BMJ 2003;326:1122-3. (Pubitemid 36613443)